The key reason why Pluristem Therapeutics Inc. (Nasdaq: PSTI) shares dipped in the premarket trading today
Pluristem Therapeutics Inc. (Nasdaq: PSTI) share nose-dived in the premarket session after the announcement by a leading regenerative medicine firm building a marketplace for new